Technology for third-generation flu vaccine developed in Russia
10 Sep '14
Russian scientists have created a new technology to develop a flu vaccine. The word came from Moscow’s NPO Microgen, a national leader in immunological solutions development and the developer of the new drug candidate.
According to Microgen, with the new technology the vaccine maker won’t need adjuvants, special immunological agents that are added to a vaccine to get the immune system to produce a higher amount of antibodies. The new approach also makes sure a patient receives cross-protection even against the flu strains which the vaccine doesn’t contain.
“The invention, for which we have obtained a patent, will enable us to produce a flu vaccine as efficient as possible. This is a third-generation vaccine,” Microgen CEO Petr Kanygin said.
The vaccine will hit the market in 2016, Microgen hopes.